arrow
N

Neil P. Robertson

institute of psychological medicine and clinical neuroscience
H指数:51
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genetic subtypes of multiple sclerosis severity are uncoupled from inflammatory lesion burden

多发性硬化严重程度的遗传亚型与炎症病灶负荷解偶联

2026-08-210
OA
Adherence to risk minimization measures for alemtuzumab use in multiple sclerosis: a drug utilization study in four European countries

在四国欧洲国家进行的阿仑单抗治疗多发性硬化风险最小化措施依从性研究

2026-05-210
PRE
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial

他汀类药物再利用对继发性进展型多发性硬化症(MS-STAT2)残疾进展的影响:一项III期、随机、双盲、安慰剂对照试验

2025-10-010
OAAI
Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis

克拉屈滨与芬戈莫德,那他珠单抗,ocrelizumab和阿仑单抗在复发缓解型多发性硬化症中的疗效比较

2024-08-010
PRE
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination

接种疫苗后血清阴性的多发性硬化症患者的新型冠状病毒肺炎风险

2023-07-115
OA
COVID-19 Vaccine Response in People with Multiple Sclerosis
2021-11-17120
OAAI